Herb-Drug Interaction Between Xiyanping Injection and Lopinavir/Ritonavir, Two Agents Used in COVID-19 Pharmacotherapy
The global epidemic outbreak of the coronavirus disease 2019 (COVID-19), which exhibits high infectivity, resulted in thousands of deaths due to the lack of specific drugs. Certain traditional Chinese medicines (TCMs), such as Xiyanping injection (XYPI), have exhibited remarkable benefits against CO...
Guardado en:
Autores principales: | Linhu Ye, Lei Cheng, Yan Deng, Hong Liu, Xinyu Wu, Tingting Wang, Qi Chang, Yan Zhang, Dan Wang, Zongze Li, Xixiao Yang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1b09b91ddebd4d7891c098450adec7a6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effectiveness of Remdesivir, Lopinavir/Ritonavir, and Favipiravir for COVID-19 Treatment: A Systematic Review
por: Qomara WF, et al.
Publicado: (2021) -
A multi-centre, randomized, double-blind, placebo-controlled clinical trial of the efficacy and safety of chloroquine phosphate, hydroxychloroquine sulphate and lopinavir/ritonavir for the treatment of COVID-19 in Lagos State: study protocol for a randomized controlled trial
por: A. Abayomi, et al.
Publicado: (2021) -
Interacciones farmacológicas en niños con infección por VIH en tratamiento con antirretrovirales
por: Castro-Moraga,María Eugenia, et al.
Publicado: (2021) -
Antiviral Combination Clinically Better Than Standard Therapy in Severe but Not in Non-Severe COVID-19
por: Panda PK, et al.
Publicado: (2021) -
Ergotismo secundario a la asociación ergotamina-ritonavir: A propósito de 3 casos
por: Acle,Santiago, et al.
Publicado: (2011)